PharmaLeaders.com

News. Resources. Community.

  • Features
  • Channels
    • Biotech Channel
    • Clinical Channel
    • CME Channel
    • Compliance Channel
    • Device Channel
    • HIMSS Channel
    • Marketing Channel
    • Pharma Channel
    • R&D Channel
    • Telehealth Channel
    • Training Channel
  • Events
  • On Demand
  • White Papers
  • Vendors
    • Biotech Vendors
    • Clinical Vendors
    • CME Vendors
    • Compliance Vendors
    • Device Vendors
    • Marketing Vendors
    • Pharma Vendors
    • R&D Vendors
    • Training Vendors
  • Contributors

Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development

04/11/2021 by PharmaLeaders Aggregator

Biotechnology company Anixa Biosciences, partnered by IT and pharma solutions company OntoChem, has announced that it will enter the next stage of development of its potential anti-viral therapy The post Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development appeared first on Pharmaceutical Business review. … [Read more...]

AB Science and University of Chicago to conduct Covid-19 treatment research

04/11/2021 by PharmaLeaders Aggregator

French pharmaceutical company AB Science has signed an exclusive licensing agreement with the University of Chicago to conduct research for the prevention and treatment of Covid-19 with masitinib The post AB Science and University of Chicago to conduct Covid-19 treatment research appeared first on Pharmaceutical Business review. … [Read more...]

AbbVie announces extension of USFDA review period for Rinvoq sNDA

04/10/2021 by PharmaLeaders Aggregator

The US Food and Drug Administration (FDA) has extended the review period for AbbVie’s supplemental New Drug Application (sNDA) for Rinvoq (upadacitinib). Rinvoq, which is discovered and developed The post AbbVie announces extension of USFDA review period for Rinvoq sNDA appeared first on Pharmaceutical Business review. … [Read more...]

Antengene announces China’s NMPA approval for IND application for ATG-019 clinical trial

04/10/2021 by PharmaLeaders Aggregator

Antengene has announced that China’s National Medical Products Administration (NMPA) has given approval to investigational new drug (IND) application for Phase I clinical trials of ATG-019 (monotherapy or The post Antengene announces China’s NMPA approval for IND application for ATG-019 clinical trial appeared first on Pharmaceutical Business review. … [Read more...]

Strategic Partnerships for Unlocking Product Potential

04/09/2021 by PharmaLeaders Aggregator

… [Read more...]

Next Page »
  • Facebook
  • LinkedIn
  • Twitter

Choose Your Channel

Receive event announcements and special reports directly in your inbox.
  • This field is for validation purposes and should be left unchanged.
DIA 2021 Global Annual Meeting

Upcoming Events

  1. Gene Therapy Analytical Development Europe 2021

    May 25 - May 27
  2. Reuters Events Pharma USA 2021

    May 25 - June 4
  3. DIA 2021 Global Annual Meeting

    June 27 - July 1

View All Events

  • About Us
  • Sponsorship
  • Join Our Team
  • Contact Us

Copyright © 2021 PharmaLeaders.com. All rights reserved.

Copyright © 2021 · Magazine Pro Theme on Genesis Framework · WordPress · Log in